They say hindsight is 2020 – and as 2021 is just around the corner – Let Svar Life Science help you obtain perfect vision for your ongoing and new drug development projects in 2021! We ended the year with a focus on retinal gene therapy – an area that is expected to continue to expand exponentially ... Read more
The right cell-based assay expertise can provide a clearer picture of what is actually occurring in the body. With the use of living cells, cell-based assays are able to produce more biologically relevant results, which is key to understanding a biotherapeutic. Although the use of living cells adds ... Read more
Gene therapy is a promising technology with the potential of helping some of the hundreds of millions of people that live with genetic disease worldwide. In recent years, there has been a surge in interest for the technology and there are a large number of ongoing clinical trials. We are witnessing ... Read more
The surge in interest for developing therapeutic antibodies in the last few years has led to increased demand for reliable cell-based assays to assess the ability of these antibodies to elicit ADCC. In this white paper, we present data on the quantification of ADCC using cell-based iLite ADCC ... Read more
